Professional
Added to YB: 2024-05-09
Pitch date: 2024-05-01
PFE [bullish]
Pfizer Inc.
+3.19%
current return
Author Info
No bio for this author
Company Info
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally.
Market Cap
$153.7B
Pitch Price
$26.03
Price Target
42.00 (+56%)
Dividend
6.34%
Sector
Pharmaceuticals
Category
value
Pfizer Inc.: Solid Results Supported by Steady Tracking Toward $4 Billion in Cost Cuts
$PFE - Wide-moat pharma giant undervalued as market underappreciates margin expansion potential from $4B in cost cuts by end of 2024. Q1 sales +11% (ex-COVID), rare disease drug Vyndaqel +66%. Risks: intensifying generics for Eliquis by 2026, Prevnar pressure from Merck's V116. $42 FVE on lower 2024 guide, but div secure. Cost cuts & new drugs to drive growth.
Read full article (8 min)